carbamazepine has been researched along with Central Nervous System Disease in 12 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Increasing evidence suggests that oxcarbazepine can provide significant analgesia in several neuropathic pain conditions, including trigeminal neuralgia and PDN, and is also may be effective in treating neuropathic pain refractory to other AEDs, such as carbamazepine and gabapentin." | 8.82 | Rationale and evidence for the use of oxcarbazepine in neuropathic pain. ( Carrazana, E; Mikoshiba, I, 2003) |
| " Increasing evidence suggests that oxcarbazepine can provide significant analgesia in several neuropathic pain conditions, including trigeminal neuralgia and PDN, and is also may be effective in treating neuropathic pain refractory to other AEDs, such as carbamazepine and gabapentin." | 4.82 | Rationale and evidence for the use of oxcarbazepine in neuropathic pain. ( Carrazana, E; Mikoshiba, I, 2003) |
| "Seven psychiatric inpatients receiving carbamazepine 600 mg/day were coadministered clarithromycin 400 mg/day for 5 days to treat atypical pneumonia." | 3.69 | Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients. ( Kaneko, S; Ohkubo, T; Otani, K; Shimoyama, R; Sugawara, K; Yasui, N, 1997) |
| " In order to use these effectively, the critical care nurse must be aware of the indications and controversies surrounding their use, the patho-physiologic conditions that impact on the disposition, and appropriate dosing and monitoring of these agents in the critical care setting." | 2.38 | Anticonvulsants: pharmacotherapeutic issues in the critically ill patient. ( Dupuis, RE; Miranda-Massari, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halilova, N | 1 |
| Carrazana, E | 1 |
| Mikoshiba, I | 1 |
| Yasui, N | 1 |
| Otani, K | 1 |
| Kaneko, S | 1 |
| Shimoyama, R | 1 |
| Ohkubo, T | 1 |
| Sugawara, K | 1 |
| Mesec, A | 1 |
| Rot, U | 1 |
| Perkovic, T | 1 |
| Lunder, T | 1 |
| Sibanc, B | 1 |
| Kontogiannis, V | 1 |
| Havlat, M | 1 |
| Lowe, JS | 1 |
| Powell, RJ | 1 |
| Kim, SJ | 1 |
| Gehlen, W | 1 |
| Dupuis, RE | 1 |
| Miranda-Massari, J | 1 |
| Minich, PJ | 1 |
| Young, WA | 1 |
| Jusić, A | 1 |
| Stimac, D | 1 |
| Amyot, R | 1 |
3 reviews available for carbamazepine and Central Nervous System Disease
| Article | Year |
|---|---|
Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
Topics: Anticonvulsants; Carbamazepine; Central Nervous System Diseases; Clinical Trials as Topic; Diabetic | 2003 |
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di | 1977 |
Anticonvulsants: pharmacotherapeutic issues in the critically ill patient.
Topics: Anticonvulsants; Benzodiazepines; Brain Injuries; Carbamazepine; Central Nervous System Diseases; Ep | 1991 |
9 other studies available for carbamazepine and Central Nervous System Disease
| Article | Year |
|---|---|
Improving the prognosis ways of central genesis and management option in infertile women.
Topics: Adolescent; Adult; Amenorrhea; Androgen Antagonists; Carbamazepine; Central Nervous System Diseases; | 2012 |
Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous Syste | 1997 |
Carbamazepine hypersensitivity syndrome presenting as vasculitis of the CNS.
Topics: Carbamazepine; Central Nervous System Diseases; Drug Hypersensitivity; Epilepsy; Female; Humans; Mid | 1999 |
Lesson of the month: Systemic vasculitis or not? That is the question.
Topics: Acetates; Amines; Anticoagulants; Anticonvulsants; Brain; Carbamazepine; Central Nervous System Dise | 1999 |
Blue rubber bleb nevus syndrome with central nervous system involvement.
Topics: Anticonvulsants; Brain; Carbamazepine; Central Nervous System Diseases; Epilepsies, Partial; Female; | 2000 |
Severe hematologic and neurologic reaction to carbamazepine.
Topics: Aged; Agranulocytosis; Carbamazepine; Central Nervous System Diseases; Hematologic Diseases; Humans; | 1985 |
Diphenylhydantoin.
Topics: Affective Symptoms; Arrhythmias, Cardiac; Ataxia; Carbamazepine; Central Nervous System Diseases; Ch | 1971 |
[Central genesis of dystrophia myotonica and Tegretal therapy].
Topics: Adult; Carbamazepine; Central Nervous System Diseases; Electromyography; Electrophysiology; Female; | 1972 |
[Treatment of neurogenic diabetes insipidus].
Topics: Anticholesteremic Agents; Carbamazepine; Central Nervous System Diseases; Chlorpropamide; Clofibrate | 1971 |